Recent Articles
U.S. Hospitals Warn About Looming Chemotherapy Shortages
Several U.S. hospitals have reported short supplies of two chemotherapy drugs, vincristine and etoposide. The former is used to treat leukemia and the latter...
Trump Administration Reveals Plans to Lower Drug Prices
In a recent speech at the White House, President Donald Trump unveiled new initiatives to curb high drug prices, including removing barriers to generic-drug...
FDA Cracks Down on Unapproved Stem Cell Clinics
The U.S. Food and Drug Administration (FDA) filed two complaints earlier this month seeking permanent injunctions against two stem cell clinics, U.S. Stem Cell...
Cancer Doctors Are Still Hazy on Medical Marijuana
According to a survey conducted by researchers at Dana-Farber Cancer Institute, many U.S. cancer doctors have recommended medical marijuana to their patients to manage...
FDA Approves First Biosimilar for Anemia Treatment
The U.S. Food and Drug Administration (FDA) approved epoetin alfa-epbx as a biosimilar to epoetin alfa for the treatment of anemia caused by chronic...
Current Issue
May 2018, Volume 4, Issue 6
This issue features a look at the hidden costs of importing lower-cost drugs, the optimal hemophilia treatment, the limits of genetic testing, and more.
